Navigation Links
Finally, light at the end of the tunnel for those suffering tunnel vision

Boston: U.S. scientists at Harvard Medical School's Schepens Eye Research Institute are optimistic about a visual device that may prove a boon// to people with tunnel vision.

During a study to gauge the success rate of the high-tech device, researchers found that there was a marked increase in the way the visually impaired were able to place their finger on objects. This contraption, which comprises of a small camera, pocket-sized computer and see-through computer display on a pair of glasses, may just be what the doctor ordered for visually impaired individuals. It is estimated that 1-in-200 Americans above the age of 55 suffer from tunnel vision.

"We are very pleased with the results of this first evaluation and hope that with further study and refinement, we may soon make this device available for the public," said Dr. Eli Peli, author of the study and the brain behind this device.

The research is published in the September issue of the Journal of Investigative Ophthalmology and Visual Science.


'"/>




Page: 1

Related medicine news :

1. Finally, The First Ever Treatment for Drug-Resistant HIV
2. Doctors operate upon patients in candlelight- latest from the quake scene
3. “Don’t fear long haul flights!” Vascular surgeon tells travelrs
4. Hazards of sunlight
5. Slightly High BP Poses Health Risk
6. Arterial stiffness prevented by light drinking
7. New light on Cardiology
8. Diet, Sunlight connected to Breast Cancer Risk
9. Dangers of sunlight
10. A ray of light on Cardiology
11. Nightlights could ward diabetic blindness
Post Your Comments:
Breaking Medicine Technology:Daniel K. Spiegelman Elected to Board of Directors of Omeros 2TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 2TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 3Giant Eagle(R) Pharmacy Receives Award for Operational Excellence 2Slumps in Pharmaceutical Profitability Tied to Insufficient Management Training 5459 1Slumps in Pharmaceutical Profitability Tied to Insufficient Management Training 5459 2Slumps in Pharmaceutical Profitability Tied to Insufficient Management Training 5459 3ZyStor Therapeutics Inc Cleared to Begin Clinical Trial for Targeted Protein Therapeutic for the Treatment of Pompe Disease 5457 1ZyStor Therapeutics Inc Cleared to Begin Clinical Trial for Targeted Protein Therapeutic for the Treatment of Pompe Disease 5457 2ZyStor Therapeutics Inc Cleared to Begin Clinical Trial for Targeted Protein Therapeutic for the Treatment of Pompe Disease 5457 3Lilly to Sell Tippecanoe Manufacturing Site to Evonik Industries 5455 1Lilly to Sell Tippecanoe Manufacturing Site to Evonik Industries 5455 2Lilly to Sell Tippecanoe Manufacturing Site to Evonik Industries 5455 3Lilly to Sell Tippecanoe Manufacturing Site to Evonik Industries 5455 4